4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000019
Principal Accounting Officer gave up 1,163 shares (to pay taxes)
- Principal Accounting Officer acquired 3,590 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Alenson Carman · Principal Accounting Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-16 | Exercise or conversion : show line 1 in the form | +790 | 974 | D | ||
| 2020-02-16 | Exercise or conversion : show line 2 in the form | +2,800 | 3,774 | D | ||
| 2020-02-18 | Shares withheld for taxes : show line 3 in the form | −1,163 | $52.01 | $60,488 | 2,611 | D |
Table II: Derivative
5 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-14 | Grant or award : show line 4 in the form Restricted stock units | +2,666 | 2,666 | D |
| 2020-02-14 | Grant or award : show line 5 in the form Restricted stock unit | +4,800 | 4,800 | D |
| 2020-02-14 | Grant or award : show line 6 in the form Stock option (right to buy) | +5,332 | 5,332 | D |
| 2020-02-16 | Exercise or conversion : show line 7 in the form Restricted stock units | −790 | 790 | D |
| 2020-02-16 | Exercise or conversion : show line 8 in the form Restricted stock units | −2,800 | 0 | D |
Loading xslF345X03/wf-form4_158214930367652.xml…